Chemical Structure (Datopotamab 01)
Datroway Injection, Powder, Lyophilized, For Solution
Product Images NDC 65597-801
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Datroway (NDC 65597-801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Daiichi Sankyo Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Datopotamab 02)
This description provides data on progression-free survival percentages for two groups ("DATROWAY" with a sample size of 365 and "lcc" with a sample size of 387) over a range of time points (from 0 to 15 months). It also indicates the number at risk for each group at various time points within the study.*
Principal Display Panel (100 mg Vial Carton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
